Therapeutic management of PI3Kα inhibitor-induced hyperglycemia with a novel glucokinase activator: Advancing the Frontier of PI3Kα inhibitor therapy

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 93bc184e8b8a909c-LAX IP: 47.97.18.252 UTC time: 2025-05-06T23:00:38+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4